Genvec to use $2.5 million grant from NIAID for the development of novel cell lines (News-Medical-Net) GenVec, Inc. (Nasdaq: GNVC) announced today that it has received a Phase 2 Small Business Innovation and Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the development of GenVec's vector production technology. [News Source]

Impaired Transport In Neurons Triggers Prion Disease (Medical News Today) A new study shows that nervous system integrity and axonal properties may play a key role in prion diseases. The findings, from researchers at the Rudolf Virchow Center and the Institute of Virology of the University of Würzburg, expand our understanding of the development of prion disease and suggest novel targets for therapeutic and diagnostic approaches in its early stages. [News Source]

New research building needs money (The Daily Evergreen) Future WSU science students should have something to look forward to, come 2012. The $35 million Global Animal Health Building, which supports WSU’s infectious disease research and diagnostic programs, is now in Phase I of construction. [News Source]

WA restaurants among country’s best (Perth Now) SYDNEY'S Quay restaurant has won top honours at the Australian Gourmet Traveller Restaurant Awards for the second year running. [News Source]